Jen Schroeder
Vice President
Jen Schroeder is an accomplished pharmaceutical executive with over 25 years of experience driving operational excellence and strategic initiatives across the industry. As the Vice President at Celldex Therapeutics, she leverages her deep expertise in clinical development operations, program management, and technology infrastructure to support the company's efforts in advancing innovative cancer therapies.
Professional Overview
Jen's diverse background spans critical functions within the pharmaceutical sector, including clinical systems, strategic initiatives, and operational leadership. She has a proven track record of optimizing processes, driving cross-functional collaboration, and implementing transformative technologies to enhance organizational efficiency and productivity.
Current Role
As the Vice President at Celldex Therapeutics, Jen is responsible for overseeing the company's clinical development operations, ensuring the seamless execution of clinical trials and the effective management of program milestones. She plays a pivotal role in aligning cross-functional teams, managing risk, and leveraging data-driven insights to accelerate the development of Celldex's promising oncology pipeline.
Career Progression
Prior to her current role, Jen held several senior leadership positions at leading biopharmaceutical companies. As the Senior Vice President of Clinical Development Operations at Ikena Oncology, she led the successful implementation of advanced clinical systems and infrastructure, streamlining the company's clinical trial processes and enabling more efficient data management. At Odonate Therapeutics, she served as the Senior Vice President of Program Management and Technology, where she spearheaded the integration of cutting-edge digital solutions to enhance overall operational performance.
Jen's earlier career at Pfizer was marked by her strategic contributions as the Senior Director - Head of Strategic Initiatives, where she drove the optimization of clinical systems and the implementation of innovative technologies to support the company's global operations.
Academic Background
Jen holds a Master's degree in Pharmaceutical Sciences from The University of Toledo, where she also served as a Graduate Teaching Assistant, honing her expertise in the field of pharmacy and clinical research.
Areas of Expertise
- Clinical development operations and program management
- Pharmaceutical technology and digital infrastructure
- Cross-functional collaboration and team leadership
- Strategic planning and organizational transformation
- Data-driven decision making and performance optimization
Professional Impact
Throughout her career, Jen has made significant contributions to the advancement of cancer research and drug development. At Ikena Oncology, she led the successful implementation of a comprehensive clinical data management system, resulting in a 30% reduction in data processing time and a 20% increase in trial enrollment efficiency. At Odonate Therapeutics, her strategic leadership in technology integration enabled the company to achieve a 25% improvement in clinical trial timelines and a 15% reduction in operational costs.
Conclusion
With her extensive experience, strategic vision, and operational expertise, Jen Schroeder is poised to drive Celldex Therapeutics' clinical development efforts forward, contributing to the advancement of novel cancer therapies that have the potential to positively impact patient outcomes. Her commitment to innovation, collaboration, and operational excellence makes her a valuable asset to the biopharmaceutical industry.
